Michael James Newman
CSO and Director at Indaptus Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Indaptus Therapeutics Inc., 3 years.
Indaptus Therapeutics Inc.
Director · CSO and Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 22, 2025 | Indaptus Therapeutics Inc. | Grant or award | +52,204 | $2.03 | $105,974 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.